Skip to main content

Loading market data...

CVS

CVS Health Corporation

NYSE • United states

$94.75

+$2.07

(+2.23%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Catalyst Evidence

No verified catalyst stored yet

Click “View” to see the stored chain of evidence (if available).

Management
Credibility
Score

CVS Health Corporation (CVS)

Unavailable

Quotes may be delayed

$121.18B

Market Cap

7,066,075

Volume

24.8

P/E Ratio

2.80%

Div Yield

CVS Health Corporation Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: ONE CVS DR., WOONSOCKET, RI
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

17 Aug 2026

CVS Health Corporation reported A director or senior management change or compensation event

CVS Health Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

13 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in CVS Health Corporation.

5 Aug 2026

CVS Health Corporation filed Form 10-Q

CVS Health Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.

5 Aug 2026

CVS Health Corporation reported Operating or financial results

CVS Health Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.

22 May 2026

CVS Health Corporation securities registration filing

CVS Health Corporation filed a registration or prospectus document concerning securities.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$11.33B

Total assets (USD)$253.77B

Total liabilities (USD)$173.87B

Shareholders' equity (USD)$79.70B

Long-term debt (USD)$63.48B

Debt due within a year (USD)$8.19B

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 30 Jun 2026

Peer Comparison - Consumer Staples

Company	Price	Market Cap
KO - The Coca-Cola Company	$92.68 Yahoo Finance	$398.76B
PEP - PepsiCo, Inc.	$134.70 Yahoo Finance	$183.56B
BUD - Anheuser-Busch InBev SA/NV	$83.15 Yahoo Finance	$163.97B
SONY - Sony Group Corporation	$25.26 Yahoo Finance	$148.93B
MNST - Monster Beverage Corporation	$46.68 Yahoo Finance	$137.17B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q2 2026	$106.10B	$4.70B	$2.98B	$2.31	10-Q · 5 Aug 2026
Q1 2026	$100.43B	$4.68B	$2.94B	$2.30	10-Q · 6 May 2026
Q4 2025	$105.69B	$2.11B	$2.94B	Unavailable	10-K · 10 Feb 2026
Q3 2025	$102.87B	−$3.21B	−$3.98B	−$3.13	10-Q · 29 Oct 2025
Q2 2025	$98.92B	$2.38B	$1.02B	$0.80	10-Q · 31 Jul 2025
Q1 2025	$94.59B	$3.37B	$1.78B	$1.41	10-Q · 1 May 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $114.59

20.9% upside potential

📈

Strong Buy

Unavailable

👍

Buy

17

⏸️

Hold

0

📉

Sell

0

17 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 01:48 UTC Targets range 107.00–125.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

26

Jun 2026

Clark James David

SVP, Cont & Chief Acct Officer

Tax withholding

$90.98 per share

454 shares

31

May 2026

Newman Brian

EVP, Chief Financial Officer

Tax withholding

$90.98 per share

2,478 shares

31

May 2026

Compton-Phillips Amy

EVP, Chief Medical Officer

Tax withholding

$90.98 per share

7,618 shares

21

May 2026

AGUIRRE FERNANDO

Director

Disposition to the company

$93.50 per share

1,563 shares

21

May 2026

ROBBINS LARRY

Director

Open-market sale

$93.45 per share

370,462 shares

20

May 2026

AGUIRRE FERNANDO

Director

Disposition to the company

$93.78 per share

30,437 shares

20

May 2026

ROBBINS LARRY

Director

Open-market sale

$93.82 per share

1,018,000 shares

19

May 2026

ROBBINS LARRY

Director

Open-market sale

$94.45 per share

1,983,538 shares

14

May 2026

AGUIRRE FERNANDO

Director

Grant or award

$97.15 per share

1,563 shares

Top Shareholders

Blackrock, Inc.

123,223,409 shares

-2.141% change

6/30/2026

Vanguard Group Inc

120,709,530 shares

1.535% change

12/31/2025

Vanguard Capital Management Llc

83,315,369 shares

0.805% change

6/30/2026

Capital World Investors

74,951,955 shares

-2.973% change

6/30/2026

State Street Corp

60,283,408 shares

1.62% change

6/30/2026

Dodge & Cox

50,012,765 shares

-3.413% change

6/30/2026

Wellington Management Group Llp

33,801,113 shares

49.776% change

6/30/2026

Geode Capital Management, Llc

29,899,653 shares

1.496% change

6/30/2026

Fmr Llc

28,920,617 shares

-7.296% change

6/30/2026

Vanguard Portfolio Management Llc

26,637,259 shares

2.461% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 01:48 UTC· 1 day ago

Research coverage and investment tools

CVS Health Corporation (CVS) is a stock listed on the New York Stock Exchange in the United States, in the Consumer Staples sector (Retail-Drug Stores and Proprietary Stores). Its last price was US$94.75 on 20 Oct 2026. That is 61% of the way from its 52-week low of US$69.51 to its 52-week high of US$110.68. It paid US$2.66 a share in dividends over the last 12 months, a dividend yield of 2.80%. The latest ex-dividend date on file is 23 Jul 2026. Its market capitalisation was US$121.18 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q2 2026	$106.10B	$4.70B	$2.98B	$2.31	—	4.4%	$5.65B	10-Q · 5 Aug 2026 (opens in a new tab)
Q1 2026	$100.43B	$4.68B	$2.94B	$2.30	—	4.7%	$3.40B	10-Q · 6 May 2026 (opens in a new tab)
Q4 2025	$105.69B	$2.11B	$2.94B	Unavailable	—	2.0%	$2.61B	10-K · 10 Feb 2026 (opens in a new tab)
Q3 2025	$102.87B	−$3.21B	−$3.98B	−$3.13	—	-3.1%	$98.00M	10-Q · 29 Oct 2025 (opens in a new tab)
Q2 2025	$98.92B	$2.38B	$1.02B	$0.80	—	2.4%	$1.29B	10-Q · 31 Jul 2025 (opens in a new tab)
Q1 2025	$94.59B	$3.37B	$1.78B	$1.41	—	3.6%	$3.81B	10-Q · 1 May 2025 (opens in a new tab)

Cash and equivalents: $11.33B
Total assets: $253.77B
Total liabilities: $173.87B
Shareholders' equity: $79.70B
Long-term debt: $63.48B
Debt due within a year: $8.19B

8-K · 17 Aug 2026 · Management change

CVS Health Corporation reported A director or senior management change or compensation event (opens in a new tab)

CVS Health Corporation filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
SCHEDULE 13G/A · 13 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in CVS Health Corporation.
10-Q · 5 Aug 2026

CVS Health Corporation filed Form 10-Q (opens in a new tab)

CVS Health Corporation submitted Form 10-Q to the SEC for the period ending Jun 30, 2026.
8-K · 5 Aug 2026

CVS Health Corporation reported Operating or financial results (opens in a new tab)

CVS Health Corporation filed an 8-K covering operating or financial results, supporting financial statements or exhibits.
S-8 · 22 May 2026

CVS Health Corporation securities registration filing (opens in a new tab)

CVS Health Corporation filed a registration or prospectus document concerning securities.

Insider	Date	Transaction	Shares	Average price	Filing
Clark James David SVP, Cont & Chief Acct Officer	26 Jun 2026	Tax withholding (F)	−454	$90.98	Form 4 (opens in a new tab)
Newman Brian EVP, Chief Financial Officer	31 May 2026	Tax withholding (F)	−2,478	$90.98	Form 4 (opens in a new tab)
Compton-Phillips Amy EVP, Chief Medical Officer	31 May 2026	Tax withholding (F)	−7,618	$90.98	Form 4 (opens in a new tab)
AGUIRRE FERNANDO Director	21 May 2026	Disposition to the company (D)	−1,563	$93.50	Form 4 (opens in a new tab)
ROBBINS LARRY Director	21 May 2026	Open-market sale (S)	−370,462	$93.45	Form 4 (opens in a new tab)
AGUIRRE FERNANDO Director	20 May 2026	Disposition to the company (D)	−30,437	$93.78	Form 4 (opens in a new tab)
ROBBINS LARRY Director	20 May 2026	Open-market sale (S)	−1,018,000	$93.82	Form 4 (opens in a new tab)
ROBBINS LARRY Director	19 May 2026	Open-market sale (S)	−1,983,538	$94.45	Form 4 (opens in a new tab)
AGUIRRE FERNANDO Director	14 May 2026	Grant or award (A)	+1,563	$97.15	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Blackrock, Inc.	6/30/2026	123,223,409	-2.141%
Vanguard Group Inc	12/31/2025	120,709,530	1.535%
Vanguard Capital Management Llc	6/30/2026	83,315,369	0.805%
Capital World Investors	6/30/2026	74,951,955	-2.973%
State Street Corp	6/30/2026	60,283,408	1.62%
Dodge & Cox	6/30/2026	50,012,765	-3.413%
Wellington Management Group Llp	6/30/2026	33,801,113	49.776%
Geode Capital Management, Llc	6/30/2026	29,899,653	1.496%
Fmr Llc	6/30/2026	28,920,617	-7.296%
Vanguard Portfolio Management Llc	6/30/2026	26,637,259	2.461%

Previous close: 92.68 USD
Day range: 93.20 – 94.91 USD
52-week range: 69.51 – 110.68 USD
Volume: 7,066,075
Market cap: $121.18B
Average volume: 7,586,740
P/E ratio: 24.8
EPS (FY 2025, diluted): 1.39 USD
Dividends (last 12 months): 2.66 USD
Dividend yield: 2.80%
Ex-dividend date: 23 Jul 2026
Shares outstanding: 1.28B
Beta (5Y monthly): 0.60

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:06 UTC· 2 hours ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 08:06 UTC· 2 hours ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for CVS yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.